Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $11,468 | 13 | 59.6% |
| Travel and Lodging | $4,950 | 18 | 25.7% |
| Food and Beverage | $2,825 | 96 | 14.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Arthrex, Inc. | $10,739 | 78 | $0 (2024) |
| Pylant Medical | $7,165 | 15 | $0 (2023) |
| Stryker Corporation | $890.23 | 13 | $0 (2022) |
| Bone Support Inc. | $115.78 | 1 | $0 (2019) |
| Organogenesis Inc. | $48.59 | 3 | $0 (2019) |
| SI-BONE, Inc. | $46.99 | 2 | $0 (2018) |
| Merck Sharp & Dohme LLC | $44.56 | 3 | $0 (2023) |
| Kowa Pharmaceuticals America, Inc. | $42.63 | 2 | $0 (2023) |
| Horizon Pharma plc | $29.44 | 2 | $0 (2017) |
| Smith+Nephew, Inc. | $20.67 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,618 | 20 | Arthrex, Inc. ($1,618) |
| 2023 | $1,983 | 24 | Arthrex, Inc. ($1,752) |
| 2022 | $4,247 | 25 | Arthrex, Inc. ($2,798) |
| 2021 | $2,076 | 13 | Pylant Medical ($1,290) |
| 2020 | $20.67 | 1 | Smith+Nephew, Inc. ($20.67) |
| 2019 | $6,658 | 30 | Arthrex, Inc. ($4,454) |
| 2018 | $1,899 | 7 | Pylant Medical ($1,820) |
| 2017 | $741.92 | 7 | Pylant Medical ($660.00) |
All Payment Transactions
127 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Arthrex, Inc. | — | Travel and Lodging | In-kind items and services | $423.33 | General |
| 02/29/2024 | Arthrex, Inc. | — | Travel and Lodging | In-kind items and services | $411.44 | General |
| 02/29/2024 | Arthrex, Inc. | — | Travel and Lodging | In-kind items and services | $411.44 | General |
| 01/21/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $56.60 | General |
| 01/21/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $24.00 | General |
| 01/21/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 01/21/2024 | Arthrex, Inc. | — | Travel and Lodging | In-kind items and services | $12.80 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $71.59 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $45.00 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $45.00 | General |
| 01/20/2024 | Arthrex, Inc. | — | Travel and Lodging | In-kind items and services | $19.05 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $10.00 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $5.00 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $5.00 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $5.00 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $5.00 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $5.00 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $5.00 | General |
| 01/19/2024 | Arthrex, Inc. | — | Travel and Lodging | In-kind items and services | $21.40 | General |
| 01/19/2024 | Arthrex, Inc. | — | Travel and Lodging | In-kind items and services | $21.38 | General |
| 12/08/2023 | Arthrex, Inc. | — | Travel and Lodging | In-kind items and services | $552.55 | General |
| 09/06/2023 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/08/2023 | ERMI LLC | — | Food and Beverage | Cash or cash equivalent | $16.87 | General |
| 05/11/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 556 | 2,067 | $200,192 | $60,186 |
| 2022 | 12 | 518 | 1,956 | $186,177 | $57,692 |
| 2021 | 14 | 621 | 3,907 | $308,923 | $107,341 |
| 2020 | 21 | 863 | 2,759 | $465,462 | $119,607 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 154 | 351 | $73,036 | $21,297 | 29.2% |
| J7331 | Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg | Office | 2023 | 15 | 1,024 | $20,860 | $10,632 | 51.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 81 | 114 | $34,997 | $9,695 | 27.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 64 | 139 | $26,562 | $6,804 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $15,542 | $3,714 | 23.9% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 24 | 32 | $8,588 | $2,287 | 26.6% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 51 | 83 | $8,155 | $2,157 | 26.4% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 26 | 33 | $3,760 | $1,087 | 28.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 61 | 182 | $3,278 | $1,049 | 32.0% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 25 | 41 | $3,288 | $978.51 | 29.8% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 11 | 12 | $1,620 | $371.50 | 22.9% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 11 | 23 | $506.23 | $114.24 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 154 | 321 | $66,794 | $19,433 | 29.1% |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 2022 | 13 | 1,072 | $22,705 | $12,715 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 94 | $28,857 | $8,228 | 28.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 55 | 119 | $23,264 | $5,965 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $17,897 | $4,148 | 23.2% |
| 73562 | X-ray of knee, 3 views | Office | 2022 | 62 | 95 | $9,236 | $2,612 | 28.3% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 14 | 17 | $4,424 | $1,263 | 28.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $4,927 | $1,157 | 23.5% |
| 73502 | X-ray of hip, 2-3 views | Office | 2022 | 22 | 26 | $2,962 | $797.77 | 26.9% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2022 | 19 | 32 | $2,566 | $759.35 | 29.6% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 29 | 69 | $1,519 | $345.36 | 22.7% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 24 | 57 | $1,027 | $268.01 | 26.1% |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 2021 | 27 | 2,801 | $59,325 | $37,724 | 63.6% |
About Dr. Gregory Zeiders, DO
Dr. Gregory Zeiders, DO is a Orthopaedic Surgery healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801868211.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Zeiders, DO has received a total of $19,243 in payments from pharmaceutical and medical device companies, with $1,618 received in 2024. These payments were reported across 127 transactions from 17 companies. The most common payment nature is "Education" ($11,468).
As a Medicare-enrolled provider, Zeiders has provided services to 2,558 Medicare beneficiaries, totaling 10,689 services with total Medicare billing of $344,826. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Orthopaedic Surgery
- Location Oklahoma City, OK
- Active Since 02/02/2006
- Last Updated 04/11/2021
- Taxonomy Code 207X00000X
- Entity Type Individual
- NPI Number 1801868211
Products in Payments
- MAKO (Device) $679.43
- KNEE & HIP IMPLANTS OTHER ACL BACKUP (Device) $116.85
- CERAMENTBONE VOID FILLER (Device) $115.78
- REUNION (Device) $86.04
- ADAPT (Device) $50.00
- iFuse Implant (Device) $46.99
- BRIDION (Drug) $44.56
- SEGLENTIS (Drug) $42.63
- GAMMA (Device) $42.50
- Apligraf (Device) $32.58
- DUEXIS (Drug) $29.44
- REGENETEN (Device) $20.67
- AXSOS (Device) $20.14
- Restrata Wound Matrix (Device) $17.27
- Durolane (Device) $16.18
- Apligraf (Biological) $16.01
- PENNSAID (Drug) $14.66
- VPULSE (Device) $12.28
- Reunion (Device) $12.12
- STRATAFIX (Device) $11.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Orthopaedic Surgery Doctors in Oklahoma City
Andrew Parkinson, Md, MD
Orthopaedic Surgery — Payments: $2.7M
Dr. Corey Ponder, M.d, M.D
Orthopaedic Surgery — Payments: $677,609
Dr. Paul Jacob, D.o, D.O
Orthopaedic Surgery — Payments: $623,583
Winston Fong, M.d, M.D
Orthopaedic Surgery — Payments: $509,423
Thomas Tkach, Md, MD
Orthopaedic Surgery — Payments: $498,383
Dr. Brett Braly, Md, MD
Orthopaedic Surgery — Payments: $340,345